These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35538392)

  • 1. Associations of Healthcare Utilization and Costs with Increasing Pain and Treatment Intensity Levels in Osteoarthritis Patients: An 18-Year Retrospective Study.
    Graham J; Novosat T; Sun H; Piper BJ; Boscarino JA; Kern MS; Hayduk VA; Wright EA; Beck C; Robinson RL; Casey E; Hall J; Dorling P
    Rheumatol Ther; 2022 Aug; 9(4):1061-1078. PubMed ID: 35538392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Pain Severity and Opioid Use on Health Care Resource Utilization and Costs Among Patients with Knee and Hip Osteoarthritis.
    Wei W; Gandhi K; Blauer-Peterson C; Johnson J
    J Manag Care Spec Pharm; 2019 Sep; 25(9):957-965. PubMed ID: 31456495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease burden on health care by pain severity and usual analgesic treatment in patients with symptomatic osteoarthritis: a Spanish nationwide health survey.
    Rejas-Gutierrez J; Llopart-Carles N; García-López S; Darbà J
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):711-719. PubMed ID: 32772591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain.
    Abraham L; Halsby K; Stein N; Wrona B; Emir B; Stevenson H
    Rheumatol Ther; 2022 Jun; 9(3):851-874. PubMed ID: 35312946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured population.
    Wang SX; Ganguli AX; Bodhani A; Medema JK; Reichmann WM; Macaulay D
    J Med Econ; 2017 Dec; 20(12):1299-1306. PubMed ID: 28880733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of pain interference and opioid use with healthcare utilization and costs, and wage loss among adults with osteoarthritis in the United States.
    Zhao X; Shah D; Gandhi K; Wei W; Dwibedi N; Webster L; Sambamoorthi U
    J Med Econ; 2019 Nov; 22(11):1192-1201. PubMed ID: 31433685
    [No Abstract]   [Full Text] [Related]  

  • 7. Pain severity and healthcare resource utilization in patients with osteoarthritis in the United States.
    Nalamachu S; Robinson RL; Viktrup L; Cappelleri JC; Bushmakin AG; Tive L; Mellor J; Hatchell N; Jackson J
    Postgrad Med; 2021 Jan; 133(1):10-19. PubMed ID: 33131380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate to Severe Osteoarthritis Pain and Its Impact on Patients in the United States: A National Survey.
    Schepman P; Thakkar S; Robinson R; Malhotra D; Emir B; Beck C
    J Pain Res; 2021; 14():2313-2326. PubMed ID: 34349555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey.
    Dibonaventura MD; Gupta S; McDonald M; Sadosky A; Pettitt D; Silverman S
    Health Qual Life Outcomes; 2012 Mar; 10():30. PubMed ID: 22420468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States.
    Schepman PB; Thakkar S; Robinson RL; Beck CG; Malhotra D; Emir B; Hansen RN
    J Health Econ Outcomes Res; 2022; 9(1):58-67. PubMed ID: 35620454
    [No Abstract]   [Full Text] [Related]  

  • 11. Disease Burden and Costs in Moderate-to-Severe Chronic Osteoarthritis Pain Refractory to Standard of Care: Ancillary Analysis of the OPIOIDS Real-World Study.
    Sicras-Mainar A; Rejas-Gutierrez J; Vargas-Negrín F; Tornero-Tornero JC; Sicras-Navarro A; Lizarraga I
    Rheumatol Ther; 2021 Mar; 8(1):303-326. PubMed ID: 33411324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    Buono JL; Mathur K; Averitt AJ; Andrae DA
    J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain.
    Rejas-Gutierrez J; Sicras-Mainar A; Darbà J
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211010599. PubMed ID: 33995603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain.
    Mapel DW; Shainline M; Paez K; Gunter M
    J Rheumatol; 2004 Mar; 31(3):573-83. PubMed ID: 14994407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of chronic pain for patients with osteoarthritis in Germany: a retrospective cohort study of claims data.
    Schild M; Müller U; von Schenck U; Prieur S; Miller R
    BMC Musculoskelet Disord; 2021 Mar; 22(1):317. PubMed ID: 33789636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity.
    Murage MJ; Anderson A; Oliveria SA; Casso D; Ojeh CK; Muram TM; Merola JF; Araujo AB
    J Med Econ; 2018 Aug; 21(8):745-754. PubMed ID: 29718756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis.
    Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
    J Med Econ; 2011; 14(4):497-507. PubMed ID: 21682606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States.
    Murimi-Worstell IB; Lin DH; Kan H; Tierce J; Wang X; Nab H; Desta B; Alexander GC; Hammond ER
    J Rheumatol; 2021 Mar; 48(3):385-393. PubMed ID: 32611669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls.
    Bedenbaugh AV; Bonafede M; Marchlewicz EH; Lee V; Tambiah J
    Clinicoecon Outcomes Res; 2021; 13():421-435. PubMed ID: 34054301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.